Novartis(US:NVS) Seeking Alphaยท2024-10-28 17:32Group 1 - The conference call is focused on Novartis AG's renal portfolio, highlighting its strategic importance and ongoing developments in this area [2][4] - Participants in the call include key executives from Novartis, such as the Head of Investor Relations and the President of Global Drug Development [1][2] - The call is being recorded and will be available for later access on the company's website, indicating a commitment to transparency and investor communication [2] Group 2 - The presentation will include forward-looking statements that may involve risks and uncertainties, which could lead to actual results differing from expectations [3] - The company emphasizes the importance of reviewing its Form 20-F and recent quarterly results for a comprehensive understanding of potential risks [3]